Folding molecular dynamics simulation of T-peptide, a HIV viral entry inhibitor: Structure, dynamics, and comparison with the experimental data.


Journal

Journal of computational chemistry
ISSN: 1096-987X
Titre abrégé: J Comput Chem
Pays: United States
ID NLM: 9878362

Informations de publication

Date de publication:
30 05 2022
Historique:
revised: 24 02 2022
received: 15 01 2022
accepted: 02 03 2022
pubmed: 26 3 2022
medline: 4 5 2022
entrez: 25 3 2022
Statut: ppublish

Résumé

Peptide T is a synthetic octapeptide fragment, which corresponds to the region 185-192 of the gp120 HIV coat protein and functions as a viral entry inhibitor. In this work, a folding molecular dynamics simulation of peptide T in a membrane-mimicking (DMSO) solution was performed with the aim of characterizing the peptide's structural and dynamical properties. We show that peptide T is highly flexible and dynamic. The main structural characteristics observed were rapidly interconverting short helical stretches and turns, with a notable preference for the formation of β-turns. The simulation also indicated that the C-terminal part appears to be more stable than the rest of the peptide, with the most preferred conformation for residues 5-8 being a β-turn. In order to validate the accuracy of the simulations, we compared our results with the experimental NMR data obtained for the T-peptide in the same solvent. In agreement with the simulation, the NMR data indicated the presence of a preferred structure in solution that was consistent with a β-turn comprising the four C-terminal residues. An additional comparison between the experimental and simulation-derived chemical shifts also showed a reasonable agreement between experiment and simulation, further validating the simulation-derived structural characterization of the T-peptide. We conclude that peptide folding simulations produce physically relevant results even when performed with organic solvents that were not part of the force field parameterization procedure.

Identifiants

pubmed: 35333419
doi: 10.1002/jcc.26850
doi:

Substances chimiques

HIV Fusion Inhibitors 0
Peptides 0
Solvents 0
Peptide T 106362-33-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

942-952

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

P. D. Kwong, R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, W. A. Hendrickson, Nature 1998, 393, 648.
D. Picone, A. Rivieccio, O. Crescenzi, G. Caliendo, V. Santagada, E. Perissutti, S. Spisani, S. Traniello, P. A. Temussi, J. Pept. Sci. 2001, 7, 197.
M. R. Ruff, L. M. Melendez-Guerrero, Q. Yang, W. Ho, J. W. Mikovits, C. B. Pert, F. A. Ruscetti, Antivir. Res. 2001, 52, 63.
C. B. Pert, J. M. Hill, M. R. Ruff, R. M. Berman, W. G. Robey, L. O. Arthur, F. W. Ruscetti, W. L. Farrar, Proc. Natl. Acad. Sci. U. S. A. 1986, 83, 9254.
D. Picone, P. A. Temussi, M. Marastoni, R. Tomatis, A. Motta, FEBS Lett. 1988, 231, 159.
D. A. Mitsikas, N. M. Glykos, PLoS One 2020, 15, e0243429.
P. S. Georgoulia, N. M. Glykos, ACS Omega 2018, 3, 14746.
T. Adamidou, K. Arvaniti, N. M. Glykos, J. Phys. Chem. B 2017, 122, 106.
A. Serafeim, G. Salamanos, K. K. Patapati, N. M. Glykos, J. Chem. Inf. Model. 2016, 56, 2035.
A. S. Baltzis, N. M. Glykos, Protein Sci. 2016, 25, 587.
P. I. Koukos, N. M. Glykos, J. Phys. Chem. B 2014, 118, 10076.
P. S. Georgoulia, N. M. Glykos, J. Phys. Chem. B 2013, 117, 5522.
D. A. Case, T. E. I. I. I. Cheatham, T. Darden, H. Gohlke, R. Luo, K. M. Merz Jr., A. Onufriev, C. Simmerling, B. Wang, R. J. Woods, J. Comput. Chem. 2005, 26, 1668.
L. Kale, R. Skeel, M. Bhandarkar, R. Brunner, A. Gursoy, N. Krawetz, J. Phillips, A. Shinozaki, K. Varadarajan, K. Schulten, J. Comput. Phys. 1999, 151, 283.
J. C. Phillips, R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, E. Villa, C. Chipot, R. D. Skeel, L. Kale, K. Schulten, J. Comput. Chem. 2005, 26, 1781.
V. Hornak, R. Abel, A. Okur, B. Strockbine, A. Roitberg, C. Simmerling, Proteins 2006, 65, 712.
K. Lindorff-Larsen, S. Piana, K. Palmo, P. Maragakis, J. L. Klepeis, R. O. Dror, D. E. Shaw, Proteins 2010, 78, 1950.
R. B. Best, G. Hummer, J. Phys. Chem. B 2009, 113, 9004.
C. Zhang, J. Ma, J. Chem. Phys. 2010, 132, 244101.
J. A. Izaguirre, S. Reich, R. D. Skeel, J. Chem. Phys. 1999, 110, 9853.
T. Darden, D. York, L. Pedersen, J. Chem. Phys. 1993, 98, 10089.
J.-P. Ryckaert, G. Ciccotti, H. J. C. Berendsen, J. Comput. Phys. 1977, 23, 327.
N. M. Glykos, J. Comput. Chem. 2006, 27, 1765.
P. I. Koukos, N. M. Glykos, J. Comput. Chem. 2013, 34, 2310.
Y. Mu, P. Nguyen, G. Stock, Proteins 2004, 58, 45.
A. Altis, P. H. Nguyen, R. Hegger, G. Stock, J. Chem. Phys. 2007, 126, 244111.
A. Altis, M. Otten, P. H. Nguyen, R. Hegger, G. Stock, J. Chem. Phys. 2008, 128, 245102.
D. Frishman, P. Argos, Proteins 1995, 23, 566.
E. Hutchinson, J. Thornton, Protein Sci. 2008, 5, 212.
Y. Shen, A. Bax, J. Biomol. NMR 2010, 48, 13.
W. Humphrey, A. Dalke, K. Schulten, J. Mol. Graph. 1996, 14, 33.
P. I. Koukos, N. M. Glykos, J. Chem. Inf. Model. 2014, 54, 209.
G. E. Crooks, G. Hon, J. M. Chandonia, S. E. Brenner, Genome Res. 2004, 14, 1188.
R. J. Abraham, J. J. Byrne, L. Griffiths, M. Perez, Magn. Reason. Chem. 2006, 44, 491.
A. D. Buckingham, T. Schaefer, W. G. Schneider, J. Chem. Phys. 1960, 32, 1227.
M.-L. Tremblay, A. W. Banks, J. K. Rainey, J. Biomol. NMR 2010, 46, 257.

Auteurs

Ioanna Gkogka (I)

Department of Molecular Biology and Genetics, Democritus University of Thrace, University Campus, Alexandroupolis, Greece.

Nicholas M Glykos (NM)

Department of Molecular Biology and Genetics, Democritus University of Thrace, University Campus, Alexandroupolis, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH